Company: IMCR
Filing Date: 2025-03-24
Form Type: PRE 14A
Source: 0001140361-25-010035
Chunk: 37

Company: Immunocore Holdings plc
Filing Date: 2025-03-24
Form: PRE 14A
Chunk 37
---
 to an employees’ share scheme would have to first be offered to our existing shareholders pro rata to their existing shareholdings before those shares could be issued to any new shareholders. If resolution 12 is passed, but resolution 13 is not, we would have no remaining disapplication of pre-emption rights as the disapplication of pre-emption rights granted at the 2021 GM related to the allotment authority granted at the 2021 GM which would have been replaced by the allotment authority granted in resolution 12. This limitation on our ability to issue shares for cash on a non-pre-emptive basis could put us at a distinct disadvantage relative to many of our peers who are not subject to such requirements, and would increase our costs and otherwise might make it difficult for us to complete equity capital financings that our board of directors considers to be in the best interests of our shareholders. Please note that the requirement to offer shares to existing shareholders does not apply where such shares are issued for non-cash consideration or pursuant to employee share schemes. Please see “Background to Resolutions 12 and 13—Share Issuance Authorization” for additional information regarding this resolution. Vote Required The approval of this resolution 13 is conditional on the approval of resolution 12 because English law requires that a pre-emption disapplication be given in respect of a particular authorization (general or specific) to allot shares. Resolution 13 will therefore not be passed unless resolution 12 is also approved, notwithstanding that shareholders may have voted to approve resolution 13. As required under English law, resolution 13 is a special resolution that requires the affirmative vote of at least 75% of the votes cast in person or by proxy at the AGM in order to be approved. THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RESOLUTION TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS. 27

TABLE OF CONTENTS

BOARD OF DIRECTORS AND CORPORATE GOVERNANCE Board of Directors Our nominees for re-election as directors at the AGM are each currently serving as members of our board of directors. Information about each such nominee is set forth in resolutions 1 through 3 and is incorporated into this section by reference. Set forth below is a list of our directors and their ages as of the date of this proxy statement.

| Name                          |     | Age |     | Position                                       |
| Bahija Jallal, Ph.D.          |     |  63 |     | Chief Executive Officer and Executive Director